|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Follicular growth during contraceptive pill or vaginal ring treatment |
| depends on the day of ovulation in the pretreatment cycle. |
| Duijkers IJ; Verhoeven CH; Dieben TO; Klipping C |
| Human Reproduction. 2004;19(11):2674-2679. |
| The aim of this study was to investigate whether the day of ovulation and the duration of a pretreatment cycle were |
| related to the degree of follicular growth during subsequent contraceptive treatment. This randomized, open-label |
| study was performed in 40 healthy female volunteers, who were randomized by a computer-generated list after |
| stratification for the ovulation day in a pretreatment cycle. They received two cycles of NuvaRing (21 subjects) or a |
| combined oral contraceptive (COC) containing 30µg ethinylestradiol and 150µg levonorgestrel (19 subjects). |
| Follicular diameter and serum hormone concentrations (FSH, LH, 17ß-estradiol, progesterone) were measured every |
| third day. Data from treatment day 20 onwards were used for analysis. In the NuvaRing users, subjects with short |
| cycles and early ovulations in the pretreatment cycle developed larger follicles during treatment than subjects with |
| longer cycles and late ovulations. In the COC users, subjects with early ovulations in the pretreatment cycle |
| developed larger follicles during treatment. The degree of follicular growth during treatment with a combined |
| hormonal contraceptive is influenced by the duration of the pretreatment cycle and particularly by the duration of the |
| follicular phase. (PubHealth.info Document ID: CONT1T 563-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Follicular growth during contraceptive pill or vaginal ring |
| treatment depends on the day of ovulation in the pretreatment cycle.", is(are) Duijkers IJ; Verhoeven CH; Dieben |
| TO; Klipping C. The source of this article is "Human Reproduction. 2004;19(11):2674-2679.". This article was |
| published in 2004 in English language(s). (PubHealth.info® Document ID: CONT1T 563-06. All rights reserved with |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |